Using a prostate-specific membrane antigen (PSMA) aptamer-SMG1 siRNA conjugate, colorectal carcinoma cell growth was significantly depressed in mice, and this therapeutic effect was more than additive when combined with 4-1BB aptamer treatment (Table 2) [142]. Here, FOLH1 is linked to colorectal carcinoma.